Merck could lose up to $630 million in revenue after CDC changes HPV vaccine recommendation

Market Intelligence Analysis

AI-Powered
Why This Matters

Merck's Gardasil HPV vaccine sales may decline due to the CDC's revised recommendation of a single dose, potentially resulting in a loss of up to $630 million in revenue.

Market Impact

Market impact analysis based on bearish sentiment with 80% confidence.

Sentiment
Bearish
AI Confidence
80%
Time Horizon
Short Term

Article Context

Note: This is a brief excerpt for context. Click below to read the full article on the original source.

The U.S. now only recommends one dose of an HPV vaccine. It used to say all children should get two to three doses of the vaccine, depending on their age.

Continue Reading
Full article on Unknown
Read Full Article
Original article published by Unknown on January 7, 2026.
Analysis and insights provided by AnalystMarkets AI.